Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Chimax 250mg tablets
0803042H0BCAAAA
|
Chimax | Flutamide | Malignant Disease and Immunosuppression | No data available |
|
Chlorambucil 5mg tablets
0801010F0AAABAB
|
Chlorambucil | Chlorambucil | Malignant Disease and Immunosuppression | No data available |
|
Chlormethine 10mg solution for injection vials
0801010W0AAAAAA
|
Chlormethine hydrochloride | Chlormethine hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Chlormethine 160micrograms/g gel
0801010W0AAABAB
|
Chlormethine hydrochloride | Chlormethine hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Ciclosporin 250mg/5ml solution for infusion ampoules
0802020G0AAAEAE
|
Ciclosporin (Systemic) | Ciclosporin | Malignant Disease and Immunosuppression | No data available |
|
Ciclosporin 50mg/1ml solution for infusion ampoules
0802020G0AAAAAA
|
Ciclosporin (Systemic) | Ciclosporin | Malignant Disease and Immunosuppression | No data available |
|
Cisplatin 100mg/100ml solution for infusion vials
0801050I0AAAFAF
|
Cisplatin | Cisplatin | Malignant Disease and Immunosuppression | No data available |
|
Cisplatin 10mg/10ml solution for infusion vials
0801050I0AAAEAE
|
Cisplatin | Cisplatin | Malignant Disease and Immunosuppression | No data available |
|
Cisplatin 50mg powder for solution for infusion vials
0801050I0AAABAB
|
Cisplatin | Cisplatin | Malignant Disease and Immunosuppression | No data available |
|
Cisplatin 50mg/50ml solution for infusion vials
0801050I0AAADAD
|
Cisplatin | Cisplatin | Malignant Disease and Immunosuppression | No data available |
|
Cladribine 10mg tablets
0802040AYAAAAAA
|
Cladribine (Immunoglobulin) | Cladribine (Immunomodulating) | Malignant Disease and Immunosuppression | No data available |
|
Cladribine 10mg/10ml solution for infusion vials
0801030C0AAAAAA
|
Cladribine | Cladribine | Malignant Disease and Immunosuppression | No data available |
|
Cladribine 10mg/5ml solution for injection vials
0801030C0AAABAB
|
Cladribine | Cladribine | Malignant Disease and Immunosuppression | No data available |
|
Clofarabine 20mg/20ml solution for infusion vials
0801030AAAAAAAA
|
Clofarabine | Clofarabine | Malignant Disease and Immunosuppression | No data available |
|
Cobimetinib 20mg tablets
0801050CIAAAAAA
|
Cobimetinib | Cobimetinib | Malignant Disease and Immunosuppression | No data available |
|
Cometriq 20mg capsules
0801050BRBBAAAA
|
Cometriq | Cabozantinib | Malignant Disease and Immunosuppression | No data available |
|
Cometriq 20mg capsules and Cometriq 80mg capsules
0801050BRBBABAB
|
Cometriq | Cabozantinib | Malignant Disease and Immunosuppression | No data available |
|
Connaught strain BCG 81mg instil vials
0802040X0AAABAB
|
Bacillus Calmette-Guerin (B.C.G.) (Immunomodulator) | Bacillus calmette-guerin (B.C.G.) | Malignant Disease and Immunosuppression | No data available |
|
Copaxone 20mg inj vials
0802040U0BBAAAA
|
Copaxone | Glatiramer acetate | Malignant Disease and Immunosuppression | No data available |
|
Copaxone 20mg/1ml solution for injection pre-filled syringes
0802040U0BBABAB
|
Copaxone | Glatiramer acetate | Malignant Disease and Immunosuppression | No data available |
|
Copaxone 40mg/1ml solution for injection pre-filled syringes
0802040U0BBACAC
|
Copaxone | Glatiramer acetate | Malignant Disease and Immunosuppression | No data available |
|
Cosmegen Lyovac 500microgram inj vials
0801020D0BBAAAA
|
Cosmegen Lyovac | Dactinomycin | Malignant Disease and Immunosuppression | No data available |
|
Cotellic 20mg tablets
0801050CIBBAAAA
|
Cotellic | Cobimetinib | Malignant Disease and Immunosuppression | No data available |
|
Crisantaspase 10,000unit inj vials
0801050J0AAAAAA
|
Crisantaspase | Crisantaspase | Malignant Disease and Immunosuppression | No data available |
|
Cyclophosphamide 100mg/5ml oral liquid
0801010H0AAARAR
|
Cyclophosphamide | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.